Credit Agricole’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,800
Closed -$265K 665
2021
Q2
$265K Hold
4,800
0.01% 329
2021
Q1
$248K Buy
4,800
+4,250
+773% +$210K 0.01% 317
2020
Q4
$24K Buy
550
+200
+57% +$7.91K ﹤0.01% 448
2020
Q3
$12K Hold
350
﹤0.01% 445
2020
Q2
$19K Hold
350
﹤0.01% 374
2020
Q1
$12K Buy
+350
New +$16.2K ﹤0.01% 401

Other funds holding AGIO

Credit Agricole's AGIO Position: Q3 2021 in Review

Credit Agricole sold out of Agios Pharmaceuticals (AGIO) in Q3 2021, closing a stake of 4,800 shares — an estimated $265K sold.

Credit Agricole first reported a position in AGIO in Q1 2020 and held it in 6 quarters. The position peaked at $265K in Q2 2021. 164 funds tracked by Wall St. Rank hold AGIO as of Q3 2021.

  • Credit Agricole reported no remaining Agios Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Credit Agricole sold 4,800 Agios Pharmaceuticals shares in Q3 2021, an estimated $265K.
  • Credit Agricole first reported a position in Agios Pharmaceuticals in Q1 2020 and held it in 6 quarters.
  • Credit Agricole's Agios Pharmaceuticals position peaked at $265K in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2021.

Based on Credit Agricole's 13F filing for Q3 2021, filed 15 Nov 2021.